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1Chapter
2D Gel Electrophoresis to Address 
Biological Issues
Domenica Scumaci and Giovanni Cuda
Abstract
Two-dimensional (2D) gel electrophoresis is a high-resolution technique for the 
study of proteome. This chapter describes how it can be applied to characterize spe-
cific differences in the proteome profile of breast cancer cells following gene target 
interference. The proteome is the complete set of proteins encoded by a genome, 
and proteomic analysis consists in profiling the whole proteins expressed in a given 
cell, tissue, organ, or organism. Proteomic expression has the main purpose of 
qualitatively and quantitatively comparing proteins expressed under physiologi-
cal and/or pathological conditions. Although it is not the unique approach used in 
modern proteomics, two-dimensional electrophoresis (2DE) is unrivaled allowing 
simultaneous separation of thousands of proteins and the detection of post-
translational modification, not predictable through genome analysis. 2DE combines 
two physical principles to separate complex protein mixtures: the isoelectric point 
and the molecular weight. The result is a gel map in which each protein isoform 
present in the sample can be visualized as a spot, analyzed, quantified, and identi-
fied by mass spectrometry analysis. Here we outline features and advantages of the 
2DE-based proteomic approach and we describe how 2DE meets biochemistry and 
molecular biology to address specific issues.
Keywords: 2D gel electrophoresis, proteomics, mass spectrometry, breast cancer, 
western blot, image analysis, silver staining, trypsin digestion
1. Introduction
Proteins are the effectors of almost all functions in living cells. The proteome is 
the complete set of proteins encoded by a genome [1, 2]. For a given organism or 
living cells, genome is a static entity, except if a peculiar mutation occurs. Proteome 
is dynamic and its composition differs under the influence of specific physiological 
and or pathological stimuli. Proteomics is the science that describes the proteome 
and provides identification and quantification of proteins, including co- and 
post-translational modifications, their localization, interactions, activities, and 
functions [3].
Resolution of thousands of proteins in a single experiment implies the 
employment of high-throughput analytical tools with high resolution, sensitiv-
ity, and reproducibility. Two-dimensional gel electrophoresis is a key separa-
tion technique for proteomic research, useful for qualitative and quantitative 
protein expression profiling. The technique has been initially applied for protein 
separation in 1975 by O′ Farrel [4]; it has been used for over three decades, and 
it is still the most widely utilized protein separation method for proteome or 
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sub-proteome analysis. The main advantage of 2DE is the capability of simulta-
neously resolving complex protein mixture, up to 10,000, allowing their quanti-
tation as well as the analysis of all post-translational modifications [5]. 2DE has 
been adopted for a variety of applications: from drug discovery to diagnostics, 
therapy, and biochemistry [6–10].
In the last decade, 2DE has been significantly improved and currently it is a 
high-resolution, reliable, and reproducible method [11–13]. 2DE coupled together 
isoelectric focusing (IEF) with sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE), resolves proteins by two independent physic principles: the 
isoelectric point (pI) in the first dimension and molecular mass (Mr) in the second 
dimension. Therefore, any modifications that may change protonable groups of a 
protein, such as those due to phosphorylation, acetylation, and alkylation, would 
greatly affect the migration rate on the first dimension, likewise modifications of 
molecular mass as glycosylation, ubiquitination, farnesylation, for example, might 
affect the migration rate on second dimension. A combination of these ptms might 
result in the vectorial addition of the two perpendicular shifts.
The result is a 2D gel map of resolved protein isoforms that may be visualized 
with either visible colorimetric method (Coomassie blue, silver stain) [14, 15] or 
fluorescent die [16]. In theory, 2DE is capable of detecting and quantifying protein 
amounts of less than 1 ng per spot.
After 2DE separation, gel images may be acquired using densitometers, and 
quantified by means of specific software for image analysis. After that, spots of 
interest are excised, destained, and analyzed by LC-MS/MS [8, 13, 17].
Here we give an overview of the technique and provide protocol useful for the 
analysis of the proteome of specific cellular line.
2. Protocol text
2.1 Methods
2.1.1 Protein isolation
Cell lines were washed twice with PBS (1X), PBS was carefully removed, and 
cells were scraped after addition of 500 μl of lysis buffer prepared in accordance 
with Table 1. Cell suspension was collected, incubated at 0°C for 30 min, and 
sonicated using Ultrasonic Baths (VWR) at 4°C for 10 s. Cell lysate was centrifuged 
at 15000×g for 20 min. The supernatant was carefully removed and stored at −80°C 
for further analysis [9].
2.1.2 Protein concentration assay
The main step of proteomic analysis is the measurement of protein extract 
concentration. An accurate protein quantitation is essential to avoid bias in the 
determination of differentially expressed proteins.
Protein content from control and treated samples was measured using the 
Bradford method (Bio-Rad) [18].
Standard curve preparation (for sample with 1–18 μg ml−1 protein)
We prepare seven dilutions of a HSA protein standard in a range from 1 to 18 μg 
protein.
A total of 10 μl of each standard solution was diluted in 790 μl of Milli-Q water. 
A total of 200 μl of Bradford reagent was added to each tube; the solution was 
mixed thoroughly and incubated at RT for 15 min in the dark.
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Buffer Components Notes
Lysis buffer
(LB)
15 mM Tris HCl pH 7.5, 120 mM sodium chloride, 
30 mM potassium chloride, dithiothreitol 0.1%, and 
Triton X-100, 0.5%, supplemented with protease and 
phosphatase inhibitor cocktail (Halt Protease Inhibitor 
Cocktail/Halt Phosphatase Inhibitor Cocktail, Thermo 
Fisher Scientific Inc.).
Add protease inhibitors 
just prior to use. The 2X 
lysis buffer can be stored 
at 4°C up to 1 month.
Rehydration 
buffer (RB)
8 M Urea, 4% CHAPS, 0.8% (v/v) carrier ampholytes 
(pH 3–10 NL), traces of bromophenol blue, and 
70 mM DTE (add as powder).
Add DTE and carrier 
ampholytes just prior 
to use. RB buffer can be 
stored at −20°C up to 6 
months.
Equilibration 
buffer A
6 M Urea, 2% (w/v/) SDS, 50 mM Tris–HCl, pH 8.8, 
30% (v/v), and 1% (w/v) dithiothreitol (DTT).
Dissolve by shaking, 
but not by heating the 
solution. All chemical 
used must be of ultrapure 
quality.
Equilibration 
buffer A
6 M Urea, 2% (w/v/) SDS, 50 mM Tris–HCl, pH 8.8, 
30% (v/v), 2.5% (w/v) iodoacetamide (IAA).
Dissolve by shaking, 
but not by heating the 
solution. All chemical 
used must be of ultrapure 
quality.
Acrylamide stock 30% acrylamide–bis solution (29:1).
SDS stock 20% SDS in MQ-water.
Tris stock 1.5 M Tris–HCl, pH 8.8.
APS stock 10% ammonium persulfate. Prepare fresh by 
dissolving 0.1 g APS in 1 
mL MQ-water.
SDS running 
buffer
(lower chamber)
25 mM Tris base, 192 mM glycine, and 0.1% SDS.
SDS running 
buffer
(upper chamber)
25 mM Tris base, 192 mM glycine, and 0.2% SDS.
Agarose sealing 
solution
1% Agarose in 1X SDS running buffer with trace of 
bromophenol blue.
Gel solution 10% acrylamide–bis solution (29:1), 37.5 M Tris–HCl, 
pH 8.8, Na2S2O3 0.025% , APS 0.1%, and TEMED 
0.04%; adjust volume using MQ-water.
Add TEMED and APS 
just before use.
Fixing solution 
(silver staining)
40% (w/v) Ethanol and 10% (w/v) acetic acid. Prepare the solution using 
Milli-Q water.
Sensiting 
solution (silver 
staining)
0.02% Sodium thiosulfate pentahydrate. Prepare the solution using 
Milli-Q water.
Silver nitrate 
solution
(silver staining)
0.2% Silver nitrate and 0.02% formaldehyde (37%). Prepare the solution using 
Milli-Q water.
Developing 
solution
(silver staining)
3% Sodium carbonate, 0.05% formaldehyde (37%), 
and 0.005% sodium thiosulfate pentahydrate.
Prepare the solution using 
Milli-Q water.
Solution must be 
prepared just before use.
Stop solution
(silver staining)
2% Acetic acid. Prepare the solution using 
Milli-Q water.
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The absorbance was measured at 595 nm using a BioPhotometer (Eppendorf). 
The assay was done in triplicate using a specific clear cuvette (UV-Vis transparent 
between 220 and 1600 nm). The BioPhotometer was calibrated on the basis of 
standard quantitative data.
About 2 μl of each protein extract was suspended in 798 μl of Milli-Q water, 
200 μl of Bradford reagent was added to the mixture, vortexed, and incubated at RT 
for 15 min in the dark. The assay was performed in triplicate. Sample absorbance 
was measured at 595 nm using a calibrated BioPhotometer (Eppendorf).
2.1.3 First dimension: isoelectric focusing (IEF)
During isoelectric focusing, proteins are resolved in function of their isoelectric 
point (pI). The pI of a protein is the value of pH at which the electrophoretic mobil-
ity is nil. The majority of proteins have a pI within pH 4–7, although some proteins 
show an extreme value of pI as histone proteins. IEF is carried out using a precast 
strip of polyacrylamide with the most appropriate pH gradient range. The use of 
immobilized pH gradient (IPG) strips improves reproducibility, resolution, and 
protein load capability.
The pH gradient is created by dissolving in the IPG a mixture of aliphatic 
polyamino-polycarboxylic acids (carrier ampholines) that under the influence of an 
electric field create a stable pH gradient.
Proteins are resolved, in addition to their amino and carboxyl group, in func-
tion of a protonable group in their side chains. When the pH < pI, a protein has a 
net positive charge and at pH > pI, it becomes negatively charged. Therefore, under 
the influence of an electric field, proteins with acidic pI migrate toward the cath-
ode and those with basic pI move toward the anode, until it reaches the strip region 
in which pH = pI. The method allows the separation of all protein isoforms [19].
In this experiment, we loaded 130 μg of each sample diluted into RB buffer 
(Table 1) during the rehydration step. When IEF is carried out for comparative 
experiments, IPG strips must have the same length and identical pH range; samples 
must be handled in parallel.
The rehydration volume is a function of strip length [19], for a strip 24 cm long, 
the appropriate volume is 480 μl. The rehydration tray was cleaned, dried, and 
leveled to ensure uniform reswelling.
Buffer Components Notes
Destaining 
solution
(Spot excision)
30 mM Potassium ferricyanide and 100 mM sodium 
thiosulfate.
Prepare the solution using 
HPLC grade water.
Gel washing 
solution (spot 
excision)
50% acetonitrile, 50 mM ammonium bicarbonate. Prepare the solution using 
HPLC grade water.
Digestion buffer 
(spot excision)
Resuspend lyophilized trypsin (20 μg/vial) in 100 μL 
of the 1 mM HCl, yielding a 0.2 μg/μL stock solution. 
Aliquot into 10 × 10 μl and place at −20°C.
To obtain the working solution, take 10 μl of this 
trypsin solution and add 500 μl of 50 mM NH4HCO3.
Prepare the solution using 
HPLC grade water.
Avoid repeated freeze-
thaw of trypsin stock 
solutions more than once.
Extraction 
solution
50% ACN–0.2% trifluoroacetic acid (TFA).
Components and notes for buffers described and used in this chapter are summarized.
Table 1. 
Buffer components.
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A total of 480 μl of RB buffer, containing the sample, was distributed along 
the reswelling slot. The strips were deprived of protective cover and carefully flat 
on the fluid with the gel side down. The strips were checked for the presence of 
bubbles below and covered with mineral oil to prevent sample evaporation and 
urea crystallization. The tray was closed with the lid and rehydration was carried 
out for 16 h at RT.
IEF conditions may vary accordingly with sample amount, sample composition, 
IPG strip length, and pH range.
After the rehydration step, the IPG strips were removed from the slot, rinsed 
with Milli-Q water, and transferred on the Ettan IPGphor ceramic tray. During IEF, 
the gel strip is sided up. The strips were overlaid with mineral oil and the movable 
electrodes were assembled properly at the cathodic and the anodic end of the strip. 
A bit piece of filter paper was positioned between the strip and the electrode to 
eliminate ion excess.
IEF was carried out on a GE Healthcare IPGphor unit at 20°C, applying 50  
uA/Strip, until a total of 70,000 Vh was reached. The following IPGphor program 
was used: (1) 300 V 3 h step, (2) 1000 V 6 h gradient, (3) 8000 V 3 h gradient, and 
(4) 8000 V 3 h step.
2.1.4 Second dimension
During SDS PAGE, IPG-focused proteins were separated according to their 
molecular weights.
For gel casting, a single gel for each IPG strip was prepared. Gel casting was done 
simultaneously. Gel caster was assembled with glass plates, separator sheets, and 
blank cassette inserts. Each component was previously cleaned and dried. Monomer 
solution was prepared according to the protocol (Table 1: gel solution) and care-
fully poured in the funnel casting.
After 2 min, the surface of each gel was layered with 2 ml of isopropanol to 
minimize exposure to oxygen. After 10 min, isopropanol was replaced with Milli-Q 
water and the gel was allowed to polymerize for at least 5 h. The gels were prepared 
concomitantly with the start of IEF and stored at 4°C until use.
Equilibration step: the equilibration step is essential to saturate focused proteins 
with SDS and allow their separation by SDS PAGE.
After IEF, IPG strips were equilibrated using 15 ml of equilibration buffer A 
(Table 1) followed by treatment with 15 ml of equilibration buffer B (Table 1)  
[19, 20]. The equilibrated IPG strip was rinsed with running buffer 1X and posi-
tioned with acidic end to the left and the plastic back facing one the higher glass 
plates, avoiding the formation of bubbles between the strip and the top of the gel.
A small piece of filter paper soaked with 10 μL of protein MW marker was 
positioned at the right side using forceps.
The strips were sealed using agarose solution. The second dimension was done 
on 10% SDS-polyacrylamide gels.
The electrophoretic unit was filled with running buffer 1X and connected with 
the MultiTemp III Thermostatic Circulator. When the temperature of the buffer 
reached the seat value of 25°C, the gels were positioned in the chamber; the empty 
slots were filled with blank cassettes. The upper chamber was positioned in the elec-
trophoretic unit and filled with running buffer 1X, SDS 0.02%. The lid was closed 
and attached to the power supply. Run was done at constant voltage (2 W/gel, 25°C) 
until the bromophenol blue dye front reached the end of the gels [20, 21].
After electrophoresis, gels were carefully removed from their gel cassettes and 
placed on a glass tray for staining.
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2.1.5 Staining with MS-compatible silver staining
Gels were stained with the MS-compatible silver staining procedure [14, 21]. The 
methods used for staining are summarized in Table 2.
2.1.6 Gel image analysis
The main aim of proteomics consists in the identification of differentially 
expressed proteins. To proceed with the 2DE analysis, the first step is the digitaliza-
tion of gel images. It has been done by Image Scanner II (GE healthcare).
The gels were scanned at 600 dpi and saved as tiff.
Subsequent analysis was performed using the Image Master 2D-Platinum 
software, version 6.0 (GE Healthcare) according to the software manual. Briefly, 
raw images were imported into the software and processed for protein detection. 
The spot auto-detect function was used for all group comparisons applying the 
following parameters: smooth 2, min area 5, saliency 1.00000. Digital images were 
checked to ensure that all the proteins present in the gel were correctly detected. 
Differences in protein expression were assessed using the relative volume (%Vol) 
option of the software. Using this option, the data becomes independent variables 
caused by differences in loading or staining [22].
Analysis was done using three independent replicates. All data were presented 
as mean ± SEM (N), where SEM is the standard error of the mean and N represents 
the number of replicates. Protein levels in every data set were compared to control 
group using unpaired t-test. We considered statistically significant a two-sided 
p-value <0.05. Excel spreadsheet (Microsoft) was used for data plotting [23].
2.1.7 Spot excision and digestion
A main issue during spot excision and digestion procedure is avoiding con-
tamination with keratins that can affect subsequent mass spectrometry analysis. 
Proper lab-equipment and dedicated reagents mast be used for protein spot 
Step Solution Volume Time
Fixing Fixing solution 500 ml 2 h
Washing Wash with 30% 
ethanol
500 ml 30 min
Sensiting Sensiting solution 500 ml 1 min
Washing Milli-Q water 500 ml 2 × 2 min
Staining Silver nitrate solution 500 ml 30 min
Rinsing Milli-Q water 500 ml 2 × 2 min
Developing Developing solution 500 ml 2 min
Developing Developing solution 500 ml Develop for the time necessary to clearly 
visualize the spot.
Stop solution Stop solution 500 ml 20 min
Washing Milli-Q water 500 ml 3 × 10 min
The table summarizes the steps used for silver staining.
Table 2. 
Silver staining steps.
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digestion. All instruments, as well as the benchtop, were meticulously cleaned 
with 70% ethanol.
Protein spots, with a differential expression profile, were manually excised from 
silver stained gel using OneTouch Plus Spotpicker (Gel company).
Gel pieces were washed with Milli-Q water and destained incubating with a 
destaining solution (Table 1) for 15 min.
The destaning solution was removed and gel spot washed three times with 200 μl 
of 200 mM NH4HCO3 pH 7.8 for 15 min; the incubation was done in a tube shaker at 
37°C. Spots were incubated with ACN for 10 min at 37°C. A total of 70 μl of trypsin 
working solution (Table 1) was added to gel pieces prior to incubation at 37°C 
overnight. Trypsin solution was carefully recovered and placed in a fresh tube (t).
Additional peptides were recovered by incubating the gel piece with extraction 
solution at 37°C for 10 min. The solution was recuperated and pooled in the fresh 
tube (t). Peptide solution was concentrated using a speedy vac [24, 25].
The resulting tryptic peptides were purified by Pierce® C18 Spin Columns 
(Thermo Fisher Scientific Inc.) according to the manufacturer’s procedure, eluted 
with 40 μL of 70% acetonitrile, and dehydrated in a vacuum evaporator [26].
2.1.7.1 Nanoscale LC-MS/MS analysis
Tryptic peptides were analyzed using Nanoscale LC-MS/MS. The analysis was 
performed as service in our mass spectrometry facility.
Chromatography analysis was done on Easy LC 1000 nanoscale liquid chroma-
tography (nanoLC) system (Thermo Fisher Scientific, Odense, Denmark) as previ-
ously reported by Scumaci et al. [23]. Purified peptides were re-suspended with 
0.1% formic acid and injected at 500 nL/min on the analytical column. A binary 
gradient was used for the elution of peptides. Mass analysis was done by means of 
a quadrupole-orbitrap mass spectrometer Q-Exactive (Thermo Fisher Scientific, 
Bremen, Germany) working in positive ion mode, using nanoelectrospray (nESI) 
potential at 1800 V. Acquisition of data was achieved with a top-5 method using 
resolution (FWHM), AGC target, and maximum injection time (ms) for full MS 
and MS/MS of, respectively, 70,000/17,500, 1e6/5e5, and 50/400. Precursor ion 
isolation was done using a mass window of 2.0 m/z, while normalized collision 
energy was 30. Ion threshold for generating MS/MS events was 2e4. Dynamic exclu-
sion was set at 15 s. Data were processed using Proteome Discoverer 1.3 (Thermo 
Fisher Scientific, Bremen, Germany), search engine was Sequest, and the HUMAN-
refprot-isoforms.fasta was used as a sequence database. Searching parameters were: 
MS tolerance 15 ppm; MS/MS tolerance 0.02 Da; fixed modifications: cysteine 
carbamidomethylation; variable modification: methionine oxidation, serine, 
threonine, and tyrosine phosphorylation; enzyme: trypsin; max. missed cleavages 
2; taxonomy Human. We consider only protein hits generated with two successful 
peptide identifications valid and acceptable [27].
2.1.8 Western blot validation
Western blot analysis of prohibitin and gelsolin was done to verify 2D gel elec-
trophoresis data. Analysis was performed on cell extracts of MCF7wt and BRCA1 
interfered MCF7.
About 50 μg of each protein extract were resolved on a 4–15% SDS PAGE precast 
gel (Bio-Rad), and blotted to a nitrocellulose membrane followed by immunoblot-
ting. The working concentration of rabbit monoclonal antibody against BRCA1 
(clone D-20, Santa Cruz was 1 μg/ml) [23].
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Anti-PHB1 (Prohibitin 1) from cell signaling technology was used at 1:1000 
dilution and Anti-Gelsolin (Santa Cruz) was used at 1:1000 dilution. The signal was 
detected using the specific horseradish peroxidase-conjugate secondary antibodies; 
blots were developed using the SuperSignal West Femto ECL substrate (Pierce). 
Densitometric software (Alliance 2.7 1D fully automated software) determined 
the percent distribution of blotted proteins after image acquisition by Alliance 2.7 
(UVITEC, Eppendorf, Milan, Italy) [28].
Data were analyzed and plotted using Excel spreadsheet (Microsoft), and 
expressed as mean ± SEM (N), where SEM represents the standard error of the 
mean and N indicates the number of experimental repeats. Unpaired t-test was used 
to compare protein levels in each data set. A two-sided p-value <0.05 was consid-
ered statistically significant.
3. Results
2D gel electrophoresis was applied to analyze the whole proteome of breast 
cancer cell expressing or not BRCA1. BRCA1 is a tumor suppressor gene, often 
mutated in hereditary breast and ovarian cancers. The gene encodes for a large 
protein involved in several cellular pathways that include DNA damage-induced 
cell cycle checkpoint activation, maintenance of genomic stability, DNA damage 
repair, as well as chromatin remodeling, protein ubiquitination, transcriptional 
regulation, and apoptosis [29]. Recently, it has been also reported that BRCA1 
is able to induce reprogramming of metabolism toward aerobic glycolysis in 
breast cancer cells [30]. Here we induce the transient inactivation of BRCA1 in 
MCF-7 cell line for 48 h by transfection with Oligo siRNA/Brca1 [20, 31]. It has 
been done by Lipofectamine 2000 reagent (Invitrogen, Paisley, UK), according 
to the manufacturer’s instructions. Oligo siRNA/Brca1 duplex was purchased 
from Sigma Aldrich and used at a final concentration of 100 nM. The silencing of 
BRCA1 was checked by western blot analysis (Figure 1). Transient knock down 
of BRCA1 was done at 48 h according to our previous results [20]. The analysis 
workflow is summarized in Figure 2. The analysis was performed using three 
biological replicates.
Using 2D gel electrophoresis, we obtained a gel map of about 500 protein spot 
for each replicate (Figure 3). Image analysis allowed to identify 25 differentially 
Figure 1. 
Gene interference. Western blot analysis confirmed BRCA1 switch off. Equal amounts of MCF7 protein extracts 
were separated on a 4–15% SDS PAGE precast gel (Bio-Rad) and transferred to a nitrocellulose membrane 
followed by immunoblotting. In each panel, the left panel is representative data of western blot analysis; the 
right panel shows densitometric analysis. Analysis was performed using three independent experiments. Data 
are mean ± SEM (N = 3). p < 0.05. In each panel, β-actin blot shows equal amounts of protein loading.
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expressed proteins. Of these, 15 protein spots were down-expressed, while 10 were 
up-regulated.
Differentially expressed proteins were manually excised, destained, trypsin 
digested, and identified using LC-MS/MS analysis. A list of identified protein is 
provided in Table 3.
2DE data were confirmed using western blot analysis for two selected candidates 
(Figure 4).
Differentially expressed protein was analyzed using Ingenuity software PA tool.
Figure 2. 
Proteomic approach work flow.
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Figure 3. 
2D gel electrophoresis maps. (a) Representative 2D gel electrophoresis maps of MCF7 wt protein extracts and 
(b) representative 2D gel electrophoresis maps of BRCA1 interfered MCF7 protein extracts. Isoelectrofocusing 
was carried out on 3–10 NL IPGstrip, 24 cm length. The second dimension was performed on 10% SDS-
PAGE. Gel images were analyzed using Decider software. Numbered spots indicate proteins that have 
statistically significant differential expression between samples according to Image master 2D Platinum 7.0 
software (GE Healthcare).
Spot 
ID
ID 
protein
Description Score Coverage Unique 
peptides
Molecular 
weight
pI BRCA1 
interfered 
MCF7/
MCF7 wt
1 P09651-3 Isoform 2 of 
Heterogeneous 
nuclear 
ribonucleoprotein 
A1 OS=Homo 
sapiens 
GN=HNRNPA1 − 
[ROA1_HUMAN]
76.57 43.07 9.00 29.37 9.14 −24.63
4 Q15102 Platelet-
activating factor 
acetylhydrolase IB 
subunit gamma 
OS=Homo sapiens 
GN=PAFAH1B3 
PE=1 SV=1 − 
[PA1B3_HUMAN]
5.59 11.26 3.00 25.72 6.84 −2.60
6 P25788-2 Isoform 2 of 
Proteasome 
subunit 
alpha type-3 
OS=Homo sapiens 
GN=PSMA3 − 
[PSA3_HUMAN]
18.38 23.79 7.00 27.63 5.33 −1.93
7 P78417 Glutathione 
S-transferase 
omega-1 
OS=Homo sapiens 
GN=GSTO1 PE=1 
SV=2 − [GSTO1_
HUMAN]
14.83 21.99 6.00 27.55 6.60 −13.10
11
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Spot 
ID
ID 
protein
Description Score Coverage Unique 
peptides
Molecular 
weight
pI BRCA1 
interfered 
MCF7/
MCF7 wt
8 P43487 Ran-specific 
GTPase-
activating protein 
OS=Homo sapiens 
GN=RANBP1 
PE=1 SV=1 
− [RANG_
HUMAN]
0.00 8.96 2.00 23.30 5.29 −3.84
9 P04792 Heat shock 
protein beta-1 
OS=Homo sapiens 
GN=HSPB1 PE=1 
SV=2 − [HSPB1_
HUMAN]
22.60 30.73 6.00 22.77 6.40 −4.42
13 P35232 Prohibitin 
OS=Homo 
sapiens GN=PHB 
PE=1 SV=1 
− [PHB_HUMAN]
46.62 45.22 11.00 29.79 5.76 −1.94
14 P43487 Ran-specific 
GTPase-
activating protein 
OS=Homo sapiens 
GN=RANBP1 
PE=1 SV=1 − 
[RANG_HUMAN]
4.76 8.96 2.00 23.30 5.29 −4.99
15 O00299 Chloride 
intracellular 
channel protein 1 
OS=Homo sapiens 
GN=CLIC1 PE=1 
SV=4 − [CLIC1_
HUMAN]
55.50 57.68 9.00 26.91 5.17 −1.15
16 P00491 Purine nucleoside 
phosphorylase 
OS=Homo sapiens 
GN=PNP PE=1 
SV=2 − [PNPH_
HUMAN]
10.39 16.96 4.00 32.10 6.95 −2.77
22 P30740 Leukocyte 
elastase inhibitor 
OS=Homo sapiens 
GN=SERPINB1 
PE=1 SV=1 − 
[ILEU_HUMAN]
25.33 27.70 10.00 42.71 6.28 2.21
24 Q9NP79 Vacuolar protein 
sorting-associated 
protein VTA1 
homolog 
OS=Homo sapiens 
GN=VTA1 PE=1 
SV=1 − [VTA1_
HUMAN]
4.65 9.45 2.00 33.86 6.29 −4.32
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Spot 
ID
ID 
protein
Description Score Coverage Unique 
peptides
Molecular 
weight
pI BRCA1 
interfered 
MCF7/
MCF7 wt
27 B7Z7E9 Aspartate 
aminotransferase 
OS=Homo sapiens 
GN=GOT1 PE=2 
SV=1 − [B7Z7E9_
HUMAN]
3.86 8.67 3.00 44.12 8.07 2.02
29 P35998 26S protease 
regulatory subunit 
7 OS=Homo sapiens 
GN=PSMC2 
PE=1 SV=3 
− [PRS7_HUMAN]
93.17 60.28 26.00 48.60 5.95 −1.45
32 F8VPV9 ATP synthase 
subunit beta 
OS=Homo sapiens 
GN=ATP5B PE=2 
SV=1 − [F8VPV9_
HUMAN]
20.60 22.39 8.00 55.27 5.40 −3.96
33 P14618 Pyruvate kinase 
isozymes M1/M2 
OS=Homo sapiens 
GN=PKM PE=1 
SV=4 − [KPYM_
HUMAN]
29.08 32.02 13.00 57.90 7.84 2.36
34 P00352 Retinal 
dehydrogenase 1 
OS=Homo sapiens 
GN=ALDH1A1 
PE=1 SV=2 − 
[AL1A1_HUMAN]
21.35 24.35 10.00 54.83 6.73 2.31
35 P14868 Aspartate--tRNA 
ligase, cytoplasmic 
OS=Homo sapiens 
GN=DARS PE=1 
SV=2 − [SYDC_
HUMAN]
7.94 8.18 4.00 57.10 6.55 2.15
36 Q9UMS4 Pre-mRNA-
processing 
factor 19 
OS=Homo sapiens 
GN=PRPF19 PE=1 
SV=1 − [PRP19_
HUMAN]
7.76 8.93 4.00 55.15 6.61 3.80
37 O43175 D-3-
phosphoglycerate 
dehydrogenase 
OS=Homo sapiens 
GN=PHGDH 
PE=1 SV=4 − 
[SERA_HUMAN]
40.04 29.08 12.00 56.61 6.71 2.16
39 B4DUR8 T-complex protein 
1 subunit gamma 
OS=Homo sapiens 
GN=CCT3 PE=2 
SV=1 − [B4DUR8_
HUMAN]
11.04 15.20 6.00 55.64 5.64 −1.85
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3.1 Pathway and network analysis
Differentially expressed proteins were connected using ingenuity pathway 
analysis (Ingenuity Systems, www.ingenuity.com). Data sets with protein identifi-
cation and quantitative data were loaded into the application that creates hypotheti-
cal networks of protein interaction based on ingenuity pathway knowledge base. 
IPA software generates a list of networks in function on their connectivity, allowing 
to associate specific biological functions to genes here included [23, 27, 29, 32].
Proteins were mapped onto three networks (Figure 5). The most representative, 
with a score of 28 and 13 focus molecules, had function associated with cancer, cel-
lular movement, and connective tissue disorders. The second network, including 12 
focus molecules with a score of 25, exhibited functions connected with free radical 
scavenging, protein synthesis, DNA replication, recombination, and repair. Finally, 
the last network grouped proteins involved in cancer, cell death and survival, and 
cell morphology.
Spot 
ID
ID 
protein
Description Score Coverage Unique 
peptides
Molecular 
weight
pI BRCA1 
interfered 
MCF7/
MCF7 wt
40 Q96RQ3 Methylcrotonyl-
CoA carboxylase 
subunit alpha, 
mitochondrial 
OS=Homo sapiens 
GN=MCCC1 PE=1 
SV=3 − [MCCA_
HUMAN]
36.71 24.69 13.00 80.42 7.78 1.84
46 P49721 Proteasome 
subunit 
beta type-2 
OS=Homo sapiens 
GN=PSMB2 PE=1 
SV=1 − [PSB2_
HUMAN]
14.09 27.86 5.00 22.82 7.02 2.90
47 P37802 Transgelin-2 
OS=Homo sapiens 
GN=TAGLN2 
PE=1 SV=3 
− [TAGL2_
HUMAN]
12.17 34.17 6.00 22.38 8.25 3.23
51 P13020-2 Isoform 2 of 
Gelsolin OS=Mus 
musculus GN=Gsn 
− [GELS_MOUSE]
10.66 4.10 3.00 80.71 5.72 −2.03
52 P60709 Actin, cytoplasmic 
1 OS=Homo 
sapiens GN=ACTB 
PE=1 SV=1 − 
[ACTB_HUMAN]
13.39 17.07 2.00 41.71 5.48 −1.15
In the table are reported mass spectrometry identifications for protein spots that resulted differentially expressed 
following 2DE analysis. For each spot are reported: spot id, gene name, identification score, number of unique peptides, 
isolectric point (pI), and molecular weight (MW). In the last columns are reported quantitative data. Data are 
reported as fold change between BRCA1-interfered breast cancer cells (MCF7) versus breast cancer cell (MCF7) wt. 
(p value < 0.05).
Table 3. 
Densitometric data of 2D gel electrophoresis and protein identification by LC-MS/MS analysis.
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Figure 4. 
Western blot analysis confirming 2DE data for gelsolin (a) and prohibitin (b). Analysis was performed on 
protein extracts from MCF7 expressing or not BRCA1. Equal amounts of MCF7 protein extracts were separated 
on a 4–15% SDS PAGE precast gel (Bio-Rad) and electrotransferred to a nitrocellulose membrane with a Trans-
blot turbo system (Biorad). Images were acquired using the Alliance 2.7 system (UVITEC, Eppendorf, Milan, 
Italy) and analyzed by Excel spreadsheet. In each panel, the left panel is representative of western blot analysis; 
the right panel shows densitometric analysis. Analysis was performed using three independent experiments. Data 
are mean ± SEM (N = 3). p < 0.05. In each panel, β-actin blot shows equal amounts of protein loading.
Figure 5. 
IPA analysis. (a) the list of networks generated from IPA analysis and significantly modulated (log p-value) 
in BRCA1-interferd MCF7 versus MCF7 wt.; the top 2 signaling networks; (b) cancer, cellular movement, and 
connective tissue disorders; (c) free radical scavenging, protein synthesis, DNA replication, recombination, and 
repair.
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4. Discussion
The aim of this work is to describe how 2D gel electrophoresis might be effec-
tively applied to provide a comprehensive, quantitative description of protein 
expression and its change under the influence of a specific biological perturbation. 
Here we provide an overview of the 2DE methodologies with special focus on the 
technical procedure.
To provide an example of the technique application, we describe the proteome 
profiling of breast cancer cells following BRCA1 interference.
Using 2D gel electrophoresis, we found that BRCA1 silencing affected the 
expression of 25 proteins belonging to different cellular compartments and impli-
cated in a variety of cellular pathways. We focused our attention on the downregu-
lation of prohibitin and gelsolin as well as the upregulation of pyruvate kinase.
Upon BRCA1 interference, we found a reduced level of prohibitin, coher-
ently with literature data that highlighted the ability of prohibitin in inhibiting 
breast cancer cell proliferation and promoting apoptosis [33]. In addition, we 
found a reduced level of gelsolin, fully in agreement with what we previously 
published [20]. Otherwise, the expression of pyruvate kinase, together with 
D-3-phosphoglycerate dehydrogenase, was found up-regulated, according with a 
metabolic shift toward glucose metabolism [34].
Although interesting, these findings deserve validations and further investiga-
tions that largely exceed the scope of this chapter. However, the approach provided 
the opportunity to highlight the capability of 2D gel electrophoresis in proteome 
profiling breast cancer cells and in detecting the specific phenotypic changes 
induced by the interference of the key gene BRCA1.
The fundamental step of our proteomic analysis was the preparation of the 
samples. Protein extracts for 2DE were done directly on a plate with a minimum 
amount of lysis buffer, to avoid contaminations with 2DE interfering substances, 
but enough to ensure the complete extraction, solubilization, and disaggregation of 
all cellular proteins avoiding proteolysis and poor recovery. This was a critical step 
because experimentally induced protein changes may be challenging to distinguish 
from biological differences under investigations. Sample protein content was care-
fully quantized and loaded using the “in-gel rehydration” procedure. The second 
dimension was performed at constant voltage and temperature. Silver staining was 
done in glass tray with accuracy, avoiding the formation of gray precipitates as well 
as the formation of the dark background caused by an extra developing.
The reproducibility of the spot pattern in gel images of different samples reflects 
the accurateness of the procedures. Moreover, the presence of spot well distributed 
on the gel with finely defined borders as well as the lack of streak and background 
staining proved the quality of 2D separation.
5. Conclusions
In this chapter, we point out the key aspects of 2D gel electrophoresis describing 
in practice the use of the technique for the proteomic profiling of breast cancer cells 
expressing or not BRCA1.
We offer an overview of methodological peculiarities, undelaying that, in spite 
of some technical limitations, 2D gel electrophoresis is still one of the major cur-
rent analytical technologies useful to investigate specific change in the profiles of 
proteome in different cells, tissues, or organism [35].
The proteome of higher eukaryotes holds a huge complexity due to dynamic 
changes in protein expression, modification, and interactions. It’s obvious that a 
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single proteomic approach is not enough to address complex biological questions, 
but we are confident that the methods, here deepened, represents a gold standard 
for the analysis of intact proteins and all relative post-translational modifications 
responsible for a peculiar phenotype or function [36–40].
2DE is unrivaled by other proteomic approach because it consents the simultane-
ous detection and quantification of thousands of proteins isoforms, not predictable 
through other techniques including genome analysis [41, 42].
We are confident that protocols and methodologies we described are going to be 
useful for all scientists interested in 2DE separation to address their own biological 
questions.
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